Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study - Locati, L D; Bossi, P; Perrone, F; Potepan, P; Crippa, F; Mariani, L; Casieri, P; Orsenigo, M; Losa, M; Bergamini, C; Liberatoscioli, C; Quattrone, P; Calderone, R G; Rinaldi, G; Pilotti, S; Licitra, L (Oral Oncol, 2009)